Active Pharmaceutical Ingredients
Product Name
CAS Number
Specification
DMF
CEP
Status
CN
PV
Alectinib
1256580-46-7
In-house
√
I
Apalutamide
956104-40-8
In-house
Q4 2026
Darolutamide
1297538-32-9
In-house
Q1 2027
Filgotinib
1802998-75-9
In-house
Q1 2027
Gilteritinib
1254053-43-4
In-house
Q1 2027
Olaparib
763113-22-0
In-house
√
I
Osimertinib mesylate
1421373-66-1
In-house
√
I
Simeprevir
606143-52-6
In-house
Q1 2027
Tocatinib
937263-43-9
In-house
Q1 2027